Article 4

Decision 2008/897/EC is amended as follows:

1. 1..

   in Article 4, paragraphs (2) and (3) are replaced by the following:

   ‘2.

   The financial contribution by the Community shall be at the rate of 50 % of the costs to be incurred by each Member State referred to in paragraph 1 for the cost of carrying out the vaccination, the laboratory tests for virological, serological and entomological surveillance and the purchase of traps and vaccines and shall not exceed:

   (a)

   EUR 4 450 000 for Belgium;

   (b)

   EUR 5 000 for Bulgaria;

   (c)

   EUR 2 350 000 for the Czech Republic;

   (d)

   EUR 50 000 for Denmark;

   (e)

   EUR 15 700 000 for Germany;

   (f)

   EUR 180 000 for Estonia;

   (g)

   EUR 800 000 for Ireland;

   (h)

   EUR 50 000 for Greece;

   (i)

   EUR 21 000 000 for Spain;

   (j)

   EUR 57 000 000 for France;

   (k)

   EUR 3 000 000 for Italy;

   (l)

   EUR 460 000 for Latvia;

   (m)

   EUR 0 for Lithuania;

   (n)

   EUR 510 000 for Luxembourg;

   (o)

   EUR 1 400 000 for Hungary;

   (p)

   EUR 5 000 for Malta;

   (q)

   EUR 50 000 for the Netherlands;

   (r)

   EUR 3 350 000 for Austria;

   (s)

   EUR 500 000 for Poland;

   (t)

   EUR 5 300 000 for Portugal;

   (u)

   EUR 250 000 for Romania;

   (v)

   EUR 910 000 for Slovenia;

   (w)

   EUR 820 000 for Finland;

   (x)

   EUR 1 550 000 for Sweden.

   3.

   The maximum of the costs to be reimbursed to the Member States for the programmes referred to in paragraph 1 shall on average not exceed:

   (a)

   for an ELISA test EUR 2,5 per test;

   (b)

   for a PCR test EUR 10 per test;

   (c)

   for the purchase of monovalent vaccines EUR 0,3 per dose;

   (d)

   for the purchase of bivalent vaccines EUR 0,45 per dose;

   (e)

   for the administration of vaccines to bovine animals EUR 1,50 per bovine animal vaccinated, regardless of the number and types of doses used;

   (f)

   for the administration of vaccines to ovine or caprine animals EUR 0,75 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.’;

2. 2..

   in Article 9(2)(l), the amount ‘EUR 1 800 000’ is replaced by ‘EUR 50 000’;

3. 3..

   in Article 13(2)(e), the amount ‘EUR 370 000’ is replaced by ‘EUR 530 000’;

4. 4..

   the following Article 15a is inserted:

   ‘Scrapie

   Article 15a

   1.

   The multi-annual programme for the monitoring and eradication of scrapie submitted by Cyprus on 18 March 2009 is hereby approved for the period from 1 January 2009 to 31 December 2010.

   2.

   The financial contribution by the Community shall be at the rate of:

   (a)

   100 % of the costs to be incurred by Cyprus for carrying out rapid tests and primary molecular tests;

   (b)

   75 % of the cost incurred by Cyprus for the compensation to owners for the value of their animals culled and destroyed in accordance with its programme for monitoring and eradication of scrapie;

   (c)

   50 % of the costs of:

   1. (i)

      the analysis of samples for genotyping;

   2. (ii)

      the purchase of preparations used for euthanasing the animals;

   3. (iii)

      personnel specifically hired for carrying out tasks within the programme;

   4. (iv)

      destruction of the carcasses.

   3.

   The maximum of the costs to be reimbursed to Cyprus for the programme referred to in paragraph 1 shall on average not exceed:

   (a)

   for tests carried out in ovine and caprine animals referred to in Part II of Chapter A of Annex III to Regulation (EC) No 999/2001 EUR 30 per test;

   (b)

   for primary molecular discriminatory tests carried out as referred to in point 3.2(c)(i) of Chapter C of Annex X to Regulation (EC) No 999/2001 EUR 175 per test;

   (c)

   for genotyping tests EUR 10 per test;

   (d)

   for culled sheep or goats 100 EUR per animal.

   4.

   The amount to be committed for 2009 shall be EUR 5 400 000.

   5.

   The amount to be committed for the year 2010 shall be decided taking into account the implementation of the programme in 2009.’